Antibody Combination Treatment
- All
- News
- Videos
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
Antibody Injection Cuts Severe COVID-19 Risk: AstraZeneca Study
An antibody combination treatment delivered through an injection has shown "statistically significant" reduction in severe Covid or death compared to placebo in non-hospitalised patients with mild-to-moderate symptomatic Covid, AstraZeneca reported
-
WHO Recommends Antibody Treatment For Critical Covid Patients. Details Here
COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organisation guidelines published in The BMJ today.
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
Antibody Injection Cuts Severe COVID-19 Risk: AstraZeneca Study
An antibody combination treatment delivered through an injection has shown "statistically significant" reduction in severe Covid or death compared to placebo in non-hospitalised patients with mild-to-moderate symptomatic Covid, AstraZeneca reported
-
WHO Recommends Antibody Treatment For Critical Covid Patients. Details Here
COVID-19 patients at high risk of hospitalisation or those with severe disease should be given a combination of two antibody treatments, according to latest World Health Organisation guidelines published in The BMJ today.
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
